Major Pharmaceuticals has recalled 12 levothyroxine sodium tablet products distributed nationwide after the FDA classified the action as a Class II recall because the medications were subpotent, according to a July 28 FDA enforcement report. The recall was initiated July…
Pharmacy
CVS Health has moved to dismiss lawsuits brought by hospital systems in New York and Michigan alleging the company diverted 340B Drug Pricing Program savings. CVS argued in a July 22 Eastern District of Michigan filing that University of Michigan…
The FDA has approved Kenvue’s Tylenol with Naproxen, the first over-the-counter combination of 650-milligram acetaminophen and 220-milligram naproxen sodium. The product combines acetaminophen and naproxen sodium in a single over-the-counter formulation and was granted three years of exclusivity by the…
ADAP Advocacy has called for oversight of the 340B Drug Pricing Program to move from HRSA to CMS. The advocacy organization said the shift would address what it described as longstanding gaps in regulatory oversight and enforcement, according to a…
Pharmaceutical prices are projected to increase 3.54% in 2027, up 0.70 percentage points from Vizient’s winter 2026 forecast, according to a July 27 report from the company. The projection excludes pharmaceutical tariffs because of uncertainty at the time of the…
Advertisement
Sanofi is experiencing “a period of intermittent supply” of its Lantus SoloStar insulin pens in the U.S. amid rising demand, the drugmaker confirmed to Becker’s July 24. Lantus SoloStar is a prefilled pen that delivers insulin glargine, a long-acting insulin…
About one-third of U.S. communities lacked a preferred pharmacy in Medicare Part D plans in 2024, with rural areas facing the greatest access gaps, according to a July 22 study published in The American Journal of Managed Care. Researchers analyzed…
Over the past decade, e-prescribing has become nearly universal, reaching 96% of all prescriptions, and real-time benefit tools built to show providers a patient’s cost and coverage at the point of prescribing are now used by more than 90% of…
Arkansas Attorney General Tim Griffin has filed a lawsuit against 13 drug manufacturers and data management firm Second Sight Solutions, alleging they unlawfully restricted healthcare providers’ access to 340B drug discounts in violation of state law. The July 22 lawsuit…
Active U.S. drug shortages increased to 227 in the second quarter of 2026, marking the third consecutive quarterly increase, according to the American Society of Health-System Pharmacists. Nearly half of all new shortages this year involve medications made by a…